Articles

Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma

Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain;
Dept. of Pediatrics - Research, The University of Texas M. D. Anderson Cancer Center, Houston
Lab. of Protein Design and Immunoengineering, Ecole Polytechnique Federale de Lausanne, Switzerland;
Department of Biosciences, U Science Tech. Universitat de Vic-Universitat Central de Catalunya
Department of Immunology and Immunotherapy, Clinic Universitary of Navarra, Spain;
Department of Immunology and Immunotherapy, Clinic Universitary of Navarra, Spain;
Josep Carreras Leukemia Research Institute/ Cell Therapy Program of the School of Medicine,Barcelona;
Department of Immunotherapy, Hospital Clinic, IDIBAPS, Barcelona,
Hospital Clinic, IDIBAPS, Josep Carreras Leukaemia Research Institute, University of Barcelona
Hospital Clinic, IDIBAPS, Josep Carreras Leukaemia Research Institute, Barcelona, Spain
Vol. 106 No. 1 (2021): January, 2021 https://doi.org/10.3324/haematol.2019.228577